BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Uncover which travel rewards program is best suited for your needs. Make the most of your rewards and enhance your travel experience.
23,083 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Rocket Lab CEO Peter Beck argues that only two firms have achieved scalable space launches, a stance that investors a...
Casey's General Stores stock jumped after a robust earnings report that topped expectations. This guide breaks down w...
Is DraftKings stock analysis signaling a sell or a hold? This deep dive breaks down how regulation, competition, and ...
As March arrives, the quantum computing space presents both risk and opportunity. This guide highlights two sturdy pi...
A leading global shipping ETF is drawing attention for its current yield and rebound potential as sea lanes remain vo...
As quantum technology moves from labs to real-world use, a single stock could unlock big gains. This article explains...
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
Investors are watching Ambarella’s path to 2027 with a focus on growth drivers, margins, and the long-term AI camera ...
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
The latest update shifts when Social Security may run short, altering planning for millions. This guide explains the ...